DOE to cut Moly-99 deals with four US firms

by Thomas Dworetzky, Contributing Reporter | February 25, 2019

The final selection, Michigan-based Niowave, just announced in mid-February that it had taken another step forward when it confirmed that it had produced several medical radioisotopes by fissioning low-enriched uranium using a superconducting electron linear accelerator.

The isotopes included Mo-99, Iodine-131 (I-131), Xenon-133 (Xe-133) and Strontium-89 (Sr-89).

Back to HCB News

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!